MariMed Inc. (MRMD)
OTCMKTS: MRMD · Delayed Price · USD
0.170
0.00 (0.00%)
Jul 22, 2024, 9:48 AM EDT - Market open
MariMed Revenue
MariMed had revenue of $152.15M in the twelve months ending March 31, 2024, with 10.97% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $37.93M with 10.33% year-over-year growth. In the year 2023, MariMed had annual revenue of $148.60M with 10.89% growth.
Revenue (ttm)
$152.15M
Revenue Growth
+10.97%
P/S Ratio
0.42
Revenue / Employee
$211,028
Employees
721
Market Cap
64.54M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 148.60M | 14.59M | 10.89% |
Dec 31, 2022 | 134.01M | 12.55M | 10.33% |
Dec 31, 2021 | 121.46M | 70.57M | 138.66% |
Dec 31, 2020 | 50.90M | 5.29M | 11.60% |
Dec 31, 2019 | 45.60M | 33.75M | 284.79% |
Dec 31, 2018 | 11.85M | 5.78M | 95.32% |
Dec 31, 2017 | 6.07M | 2.50M | 70.25% |
Dec 31, 2016 | 3.56M | 2.29M | 180.60% |
Dec 31, 2015 | 1.27M | 1.18M | 1,337.11% |
Dec 31, 2014 | 88.38K | 87.48K | 9,676.99% |
Dec 31, 2013 | 904.00 | 119.00 | 15.16% |
Dec 31, 2012 | 785.00 | -124.82K | -99.38% |
Dec 31, 2011 | 125.61K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 379.49B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 48.86B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Eli Lilly | 35.93B |
MRMD News
- 2 hours ago - MariMed Commences Operations In Newly Expanded Area of Maryland Cultivation Facility - GlobeNewsWire
- 13 days ago - MariMed Announces Second Quarter 2024 Earnings Date - GlobeNewsWire
- 20 days ago - MariMed Announces Approval of Adult-Use Sales At Panacea Wellness Dispensary in Quincy, Massachusetts and Updates for Ohio and Maryland - GlobeNewsWire
- 20 days ago - MariMed Closes Acquisition of Second Maryland Dispensary - GlobeNewsWire
- 2 months ago - MariMed Reports First Quarter 2024 Earnings - GlobeNewsWire
- 2 months ago - Statement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration's Decision To Recategorize Cannabis To Schedule III - GlobeNewsWire
- 3 months ago - 3 Marijuana Stocks To Add To Your Watchlist This Week - MarijuanaStocks
- 3 months ago - MariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois Dispensary - GlobeNewsWire